[go: up one dir, main page]

IS2419B - Glýsín-setin þíeno[2,3-d]pýrimidín með sameinaða LH og FSH gerandefnisvirkni - Google Patents

Glýsín-setin þíeno[2,3-d]pýrimidín með sameinaða LH og FSH gerandefnisvirkni

Info

Publication number
IS2419B
IS2419B IS7152A IS7152A IS2419B IS 2419 B IS2419 B IS 2419B IS 7152 A IS7152 A IS 7152A IS 7152 A IS7152 A IS 7152A IS 2419 B IS2419 B IS 2419B
Authority
IS
Iceland
Prior art keywords
sup
alkyl
hydroxy
glycine
pyrimidine
Prior art date
Application number
IS7152A
Other languages
English (en)
Other versions
IS7152A (is
Inventor
Gerard Jules Marie Hanssen Robert
Marius Timmers Cornelis
Kelder Jan
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of IS7152A publication Critical patent/IS7152A/is
Publication of IS2419B publication Critical patent/IS2419B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS7152A 2001-09-04 2004-02-13 Glýsín-setin þíeno[2,3-d]pýrimidín með sameinaða LH og FSH gerandefnisvirkni IS2419B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01203328 2001-09-04
PCT/EP2002/009648 WO2003020727A1 (en) 2001-09-04 2002-08-29 GLYCINE-SUBSTITUTED THIENO [2,3-d]PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY

Publications (2)

Publication Number Publication Date
IS7152A IS7152A (is) 2004-02-13
IS2419B true IS2419B (is) 2008-10-15

Family

ID=8180877

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7152A IS2419B (is) 2001-09-04 2004-02-13 Glýsín-setin þíeno[2,3-d]pýrimidín með sameinaða LH og FSH gerandefnisvirkni

Country Status (27)

Country Link
US (1) US7375109B2 (is)
EP (1) EP1427734B1 (is)
JP (1) JP4263094B2 (is)
KR (1) KR100891630B1 (is)
CN (1) CN1261437C (is)
AR (1) AR036408A1 (is)
AT (1) ATE309251T1 (is)
AU (1) AU2002333750B2 (is)
BR (1) BR0212173A (is)
CA (1) CA2457212C (is)
CY (1) CY1106052T1 (is)
DE (1) DE60207280T2 (is)
DK (1) DK1427734T3 (is)
EC (1) ECSP044990A (is)
ES (1) ES2252540T3 (is)
HR (1) HRP20040194A2 (is)
HU (1) HUP0401443A3 (is)
IL (2) IL160194A0 (is)
IS (1) IS2419B (is)
MX (1) MXPA04002046A (is)
NO (1) NO328792B1 (is)
NZ (1) NZ531375A (is)
PE (1) PE20030467A1 (is)
PL (1) PL368388A1 (is)
RU (1) RU2294331C2 (is)
WO (1) WO2003020727A1 (is)
ZA (1) ZA200401459B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890923B2 (en) * 2002-12-16 2005-05-10 Astrazeneca Ab Compounds
KR100666484B1 (ko) * 2005-02-04 2007-01-09 삼성전자주식회사 반도체 메모리 장치의 입출력 회로 및 입출력 방법
WO2010047674A1 (en) 2008-10-20 2010-04-29 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
CN101762915B (zh) * 2008-12-24 2013-04-17 北京京东方光电科技有限公司 Tft-lcd阵列基板及其驱动方法
CA2789818A1 (en) 2010-04-08 2011-10-13 The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services Inverse agonists and neutral antagonists for the tsh receptor
EP3415517B1 (en) 2012-09-28 2022-04-20 Takeda Pharmaceutical Company Limited Crystalline form of 1-(4-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno(2,3-d)-pyrimidin-6yl)phenyl)-3-methoxyurea
JP2022551316A (ja) 2019-10-10 2022-12-08 ミオバント サイエンシズ ゲーエムベーハー Ｎ－（４－（１－（２，６－ジフルオロベンジル）－５－（（ジメチルアミノ）メチル）－３－（６－メトキシ－３－ピリダジニル）－２，４－ジオキソ－１，２，３，４－テトラヒドロチエノ［２，３－ｄ］ピリミジン－６－イル）フェニル）－Ｎ’－メトキシ尿素の結晶形

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2054784T3 (es) 1987-08-08 1994-08-16 Akzo Nv Un metodo para la fabricacion de un implante.
DE19632423A1 (de) * 1996-08-12 1998-02-19 Merck Patent Gmbh Thienopyrimidine
TW564247B (en) * 1999-04-08 2003-12-01 Akzo Nobel Nv Bicyclic heteraromatic compound

Also Published As

Publication number Publication date
AR036408A1 (es) 2004-09-08
NO328792B1 (no) 2010-05-18
PE20030467A1 (es) 2003-05-26
CN1261437C (zh) 2006-06-28
PL368388A1 (en) 2005-03-21
EP1427734A1 (en) 2004-06-16
US20040180907A1 (en) 2004-09-16
NZ531375A (en) 2005-06-24
NO20040922L (no) 2004-03-03
ATE309251T1 (de) 2005-11-15
JP2005504784A (ja) 2005-02-17
WO2003020727A1 (en) 2003-03-13
DE60207280T2 (de) 2006-05-18
IL160194A (en) 2009-06-15
DE60207280D1 (de) 2005-12-15
HUP0401443A3 (en) 2008-05-28
CY1106052T1 (el) 2011-04-06
KR20040029135A (ko) 2004-04-03
ZA200401459B (en) 2004-11-22
DK1427734T3 (da) 2006-03-06
HUP0401443A2 (hu) 2004-11-29
JP4263094B2 (ja) 2009-05-13
ECSP044990A (es) 2004-04-28
BR0212173A (pt) 2004-07-20
RU2004110036A (ru) 2005-10-10
EP1427734B1 (en) 2005-11-09
ES2252540T3 (es) 2006-05-16
CN1551883A (zh) 2004-12-01
IL160194A0 (en) 2004-07-25
AU2002333750B2 (en) 2008-02-21
CA2457212C (en) 2011-02-15
US7375109B2 (en) 2008-05-20
MXPA04002046A (es) 2004-07-16
KR100891630B1 (ko) 2009-04-03
IS7152A (is) 2004-02-13
RU2294331C2 (ru) 2007-02-27
HRP20040194A2 (en) 2004-08-31
CA2457212A1 (en) 2003-03-13

Similar Documents

Publication Publication Date Title
BG103785A (en) Pyrrolo[2,3-d]pyrimidines and their application as tyrosine kinase inhibitors
CA2455181A1 (en) Benzimidazo[4,5-f]isoquinolinone derivatives
MXPA06000716A (es) Derivados de quinolina y quinazolina que tienen afinidad hacia receptores del tipo 5ht1.
WO2003106428A8 (fr) Derives d'arylsulfonamides et leur utilisation en tant que antagonistes au recepteur b1 de la bradykinine
BG104248A (en) Benzamidoxim derivatives, intermediate products and methods for preparing and using them as fungicides
CA2037630A1 (en) Nitrogen-containing heterocylic compounds, their production and use
DK1442019T3 (da) Amidderivater som glycogensynthasekinase 3- beta-inhibitorer
DK1646389T3 (da) Pyrimidin-2,4-dionderivater som gonadotropinfrigörende hormonreceptorantagonister
CA2209598A1 (en) Aryl and heteroaryl purine compounds
TW359670B (en) Process for producing quinazolin-4-one derivatives
GB9625045D0 (en) Parasiticidal compounds
YU55603A (sh) Derivati purina kao antagonisti purinergiskog receptora
AU2413995A (en) Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
RU2009105823A (ru) Производные пиримидина и их применение в качестве пестицидов
IS2419B (is) Glýsín-setin þíeno[2,3-d]pýrimidín með sameinaða LH og FSH gerandefnisvirkni
CA2302943A1 (en) Phthalazine compounds and therapeutic agents for erectile dysfunction
IS2424B (is) Þíenó[2,3-d]pýrimidín með sameinaðri LH og FSH gerandefnisvirkni
HRP20030610B1 (en) Process for the preparation of mesylates of piperazine derivatives
DE60016786D1 (de) Bicyclische vasopressin-agoniste
MY130750A (en) Pyrimidine derivatives useful as selective cox-2 inhibitors
MXPA04002838A (es) Derivados de alquilaminopiridazinona sustituidos, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
EA200400770A1 (ru) Производные 5-(пиридин-3-ил)-1-азабицикло[3.2.1]октана, их получение и применение в терапии
WO2004078101A3 (en) Urea derivatives having vanilloid receptor antagonist activity
ATE398131T1 (de) Kondensierte camptothecine als antitumormittel
DE60002292D1 (de) (3,4-dihydro-2h-benzo[1,4]oxazinyl-methyl)-3-(1h-indol-3-yl)-alkylamine